Skip to content

Evaluation of comparative efficacy of Transcutaneous Auricular Vagal Nerve Stimulation with conventional physiotherapy as against Transcutaneous Supra-orbital Nerve Stimulation with conventional physiotherapy in the management of migraine: A Randomized Controlled Trial

Evaluation of comparative efficacy of Transcutaneous Auricular Vagal Nerve Stimulation with conventional physiotherapy as against Transcutaneous Supra-orbital Nerve Stimulation with conventional physiotherapy in the management of migraine: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100045
Enrollment
80
Registered
2026-01-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G890- Central pain syndrome

Interventions

Intervention1: Transcutaneous Supraorbital nerve stimulation: electrical impulses are transmitted transcutaneously via the supraorbital electrode to excite (trigger action potentials) on the supraorbi

Sponsors

Datta Meghe Institude of Higher Education and Research Ravi Nair Physiotherapy College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 3.Diagnosed with chronic migraine by a neurologist. 4.Had more than 3 months of migraine history. 5.Participants have used prophylactic medication for migraine for the past 3 months. 6.Had 2 to 8 times migraine attacks in the past 2 months.

Exclusion criteria

Exclusion criteria: 1.Presence of neurological disease other than migraine. 2.Presence of degenerative cervical condition. 3.Presence of tension-type headache before the diagnosis of migraine 4.History of Vertigo. 5.History of hypertension. 6.Process of addiction in medication

Design outcomes

Primary

MeasureTime frame
1.VAS score 2.Headache frequency or times (headache days per month) 3.Incidence of migraine attack (per 4 weeks or per month) 4.HIT-6 Timepoint: 1.VAS score 2.Headache frequency or times (headache days per month) 3.Incidence of migraine attack (per 4 weeks or per month) 4.HIT-6

Secondary

MeasureTime frame
1.MIDAS 2.Neck Disability Index 3.Cervical ROM Timepoint: 1.MIDAS 2.Neck Disability Index 3.Cervical ROM

Countries

India

Contacts

Public ContactDr Soumik Basu

Ravi Nair Physiotherapy College, Datta Meghe Institude of Higher education and Research Center.

soumik.rnpc@dmiher.edu.in09762165015

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 17, 2026